Skip to main content
. Author manuscript; available in PMC: 2019 Feb 19.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Oct 1;79(2):e52–e55. doi: 10.1097/QAI.0000000000001800

Table 2: Performance of the unadjusted Amsterdam Score.

Parameters shown are for the Amsterdam Score applied to the entire sample (N=757) with missing variables retained. The optimal cut-off using Youden’s index is underlined. +LR, positive likelihood ratio; -LR, negative likelihood ratio.

Cut off Specificity(%) Sensitivity(%) +LR -LR
≥0 0 100 1 N/A
≥0.9 39.4 98.2 1.62 0.05
≥1.1 48.7 95.5 1.86 0.09
≥1.5 79.9 79.1 3.94 0.26
≥1.6 81.0 78.2 4.11 0.27
≥2 82.8 74.5 4.35 0.31
≥2.4 92.6 65.5 8.82 0.37
≥2.5 93.2 64.5 9.49 0.38
≥2.6 93.8 61.8 10.00 0.41
≥2.7 94.7 60 11.42 0.42
≥2.9 96.6 51.8 15.24 0.50
≥3.1 96.9 51.8 16.76 0.50
≥3.5 97.4 49.1 18.68 0.52
≥3.6 97.7 46.4 20.00 0.55
≥4 98.8 21.8 17.65 0.79
≥4.1 98.8 20.9 16.91 0.80
≥4.2 98.9 20.9 19.33 0.80
≥4.4 99.2 13.6 17.65 0.87
≥4.5 99.4 13.6 22.06 0.87
≥5.1 99.4 10.9 17.65 0.90
≥5.6 99.8 3.6 23.53 0.97
≥5.8 100 3.6 N/A 0.97
≥6 100 2.7 N/A 0.97